Cocoon Capital announced a series of updates in response to a challenging year for the Southeast Asian venture capital landscape in 2024.
Cocoon Capital announced it has commenced fundraising for Fund III, aiming to continue its focus on pre-seed and seed investments in B2B deeptech startups in Southeast Asia. Each investment will have an initial size of up to US$1.5 million, with plans for around five investments annually.
The Singapore-based early-stage investor reviewed over 3,000 deals, made three new investments, and expanded its regional coverage to include Australia, India, and Bangladesh.
The firm highlighted milestones achieved by its portfolio companies. Bangladeshi startup Shomvob reached over a million users within six months after receiving pre-seed investment. Meanwhile, Singapore-based Aleph Technologies is employing AI to enhance operational efficiency in industrial settings. ArrowBiome explores bacteria-targeting biotech for applications in skincare and gut health.
Several of Cocoon’s portfolio companies secured new funding rounds in 2024. Logistics tech firm Transtrack raised US$12 million in its series A round. Aprisium obtained US$7 million to develop its real-time contaminant detection technology.
Cocoon Capital plans to continue supporting early-stage startups while hosting various events and initiatives throughout 2025.
Source:TechinAsia
#medtechstartup #medtechstartupinindia #dseidehealthcarenetwork
Cocoon Capital announced it has commenced fundraising for Fund III, aiming to continue its focus on pre-seed and seed investments in B2B deeptech startups in Southeast Asia. Each investment will have an initial size of up to US$1.5 million, with plans for around five investments annually.
The Singapore-based early-stage investor reviewed over 3,000 deals, made three new investments, and expanded its regional coverage to include Australia, India, and Bangladesh.
The firm highlighted milestones achieved by its portfolio companies. Bangladeshi startup Shomvob reached over a million users within six months after receiving pre-seed investment. Meanwhile, Singapore-based Aleph Technologies is employing AI to enhance operational efficiency in industrial settings. ArrowBiome explores bacteria-targeting biotech for applications in skincare and gut health.
Several of Cocoon’s portfolio companies secured new funding rounds in 2024. Logistics tech firm Transtrack raised US$12 million in its series A round. Aprisium obtained US$7 million to develop its real-time contaminant detection technology.
Cocoon Capital plans to continue supporting early-stage startups while hosting various events and initiatives throughout 2025.
Source:TechinAsia
#medtechstartup #medtechstartupinindia #dseidehealthcarenetwork
Cocoon Capital announced a series of updates in response to a challenging year for the Southeast Asian venture capital landscape in 2024.
Cocoon Capital announced it has commenced fundraising for Fund III, aiming to continue its focus on pre-seed and seed investments in B2B deeptech startups in Southeast Asia. Each investment will have an initial size of up to US$1.5 million, with plans for around five investments annually.
The Singapore-based early-stage investor reviewed over 3,000 deals, made three new investments, and expanded its regional coverage to include Australia, India, and Bangladesh.
The firm highlighted milestones achieved by its portfolio companies. Bangladeshi startup Shomvob reached over a million users within six months after receiving pre-seed investment. Meanwhile, Singapore-based Aleph Technologies is employing AI to enhance operational efficiency in industrial settings. ArrowBiome explores bacteria-targeting biotech for applications in skincare and gut health.
Several of Cocoon’s portfolio companies secured new funding rounds in 2024. Logistics tech firm Transtrack raised US$12 million in its series A round. Aprisium obtained US$7 million to develop its real-time contaminant detection technology.
Cocoon Capital plans to continue supporting early-stage startups while hosting various events and initiatives throughout 2025.
Source:TechinAsia
#medtechstartup #medtechstartupinindia #dseidehealthcarenetwork
